Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:MUR
NYSE:MUROil and Gas

Assessing Murphy Oil (MUR) Valuation After Strong Recent Share Price Momentum

Murphy Oil (MUR) has drawn attention after a strong share price move, with returns around 34% over the past month and 35% in the past 3 months, prompting fresh interest in its valuation. See our latest analysis for Murphy Oil. The recent 33.7% 1 month share price return and 35.2% 3 month share price return sit alongside a 29.6% year to date share price return and 56.1% 1 year total shareholder return. Together, these figures point to strong momentum that could reflect shifting expectations...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Assessing FuboTV (FUBO) Valuation After Reverse Split, Earnings Miss And Sharp Share Price Decline

FuboTV (FUBO) is back in focus after a 1-for-12 reverse stock split and a sharp share price drop, as weaker than expected earnings and ongoing cash burn unsettled many investors. See our latest analysis for FuboTV. The recent 1-for-12 reverse stock split and earnings miss have come against a weak backdrop, with a 7 day share price return of 31.57% decline and a 1 year total shareholder return of 73.33% loss. This points to fading momentum as concerns around cash burn grow. If this kind of...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Reassessing ACM Research (ACMR) Valuation After Recent Share Price Weakness

ACM Research (ACMR) has been drawing attention after recent share price pressure, with the stock down 2.7% over the past day and 41.5% over the past month. That shift is prompting investors to revisit the company’s fundamentals. See our latest analysis for ACM Research. At the current share price of US$40.07, ACM Research’s short term share price return has been weak, with a 30 day share price decline of 41.5%. However, the 1 year total shareholder return of 62.8% and 3 year total shareholder...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics Obesity Trial Success Puts Valuation Gap In Focus

Structure Therapeutics (NasdaqGM:GPCR) released highly positive Phase 2 topline data for its oral GLP-1 receptor agonist aleniglipron in obesity and overweight patients. The new results from the ACCESS clinical program show significant weight loss, a compelling safety and tolerability profile, and low discontinuation rates. The company plans to advance aleniglipron into Phase 3 trials based on these Phase 2 outcomes. Structure Therapeutics focuses on small molecule medicines, and...
BATS:CBOE
BATS:CBOECapital Markets

Assessing Cboe Global Markets (CBOE) Valuation After Mixed Recent Share Price Performance

Cboe Global Markets stock triggered by recent performance trends Cboe Global Markets (CBOE) has drawn fresh attention after recent share price moves, including a 2.4% decline over the past day and a 6.3% drop over the past month, despite a positive past 3 months return. See our latest analysis for Cboe Global Markets. While the recent 1 day and 1 month share price declines suggest some momentum is fading in the short term, the 10.03% year to date share price return and 23.97% 1 year total...
NYSE:BROS
NYSE:BROSHospitality

Is It Time To Reassess Dutch Bros (BROS) After Recent Share Price Pullback?

Wondering whether Dutch Bros at around US$46.69 still makes sense for your portfolio, or if the price now bakes in too much optimism. The stock has had a mixed run, with a 6.6% decline over the last week, an 8.2% decline over the past month, a 24.9% decline year to date, yet a 47.6% return over three years. Recent coverage has focused on how Dutch Bros fits into the broader consumer services space and how sentiment toward growth oriented concepts has shifted over time. This context helps...
NYSE:FND
NYSE:FNDSpecialty Retail

A Look At Floor & Decor (FND) Valuation After New Store Openings In Syracuse Bethel Park And Grapevine

Floor & Decor Holdings (FND) is expanding its warehouse store and design center footprint, with new openings in Syracuse, Bethel Park, and Grapevine that highlight ongoing store growth and fresh engagement with local customers and trade professionals. See our latest analysis for Floor & Decor Holdings. Despite the fresh store openings and local promotions, the share price has had a weak patch, with a 30 day share price return of a 26.62% decline and a 1 year total shareholder return of a...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

Is CSX’s Locomotive Upgrades and Maine Branch Revival Altering The Investment Case For CSX (CSX)?

Earlier this year, CSX announced a US$670 million agreement with Wabtec to upgrade its locomotive fleet with modern Evolution Series units, while partner TransloadX moved to revive two largely dormant Maine branch lines leased from CSX to support regional industrial rail activity. Together, these steps point to CSX pairing long-term efficiency upgrades in its core network with efforts to reactivate underused rail corridors through third-party investment. Next, we’ll examine how CSX’s US$670...
TSX:APM
TSX:APMMetals and Mining

Andean Precious Metals Leadership Shift During NYSE Listing And Growth Plans

Andean Precious Metals (TSX:APM) has announced that President and Director Mr. Yohann Bouchard will depart the company effective March 31, 2026. The leadership change comes as the company works toward a planned New York Stock Exchange listing and an updated technical report at Golden Queen. For investors watching Andean Precious Metals at a share price of CA$6.36, this leadership change follows a mixed run in the stock. The shares are up 12.6% over the past week, while showing a 39.4%...
NYSE:DLB
NYSE:DLBSoftware

Is Dolby Laboratories (DLB) Offering Value After Recent Share Price Pullback

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...
NYSE:TGT
NYSE:TGTConsumer Retailing

Is It Time To Reconsider Target (TGT) After Its Recent Share Price Recovery?

If you are asking whether Target is priced fairly today, the starting point is understanding how the current share price lines up with different measures of value. The stock closed at US$119.84, with returns of 5.8% over 7 days, 2.9% over 30 days, 19.2% year to date, 20.9% over 1 year, and declines of 19.4% over 3 years and 31.0% over 5 years. Taken together, this gives you a mixed picture of both recent momentum and longer term risk. These moves sit against a backdrop where investors have...
NYSE:TTI
NYSE:TTIEnergy Services

Assessing TETRA Technologies (TTI) Valuation After Mixed Recent Share Performance

Recent performance and what it might mean for TETRA Technologies (TTI) TETRA Technologies (TTI) has seen mixed share performance recently, with a 2.6% gain over the past day and 8.3% over the past week, compared with a decline of 22.6% over the past month and a 7.7% decline over the past three months. See our latest analysis for TETRA Technologies. Looking past the latest bounce, the 30 day share price return of negative 22.6% and year to date share price return of negative 11.95% sit against...
NYSE:FHN
NYSE:FHNBanks

Assessing First Horizon (FHN) Valuation After Recent Share Price Weakness And Perceived Undervaluation

First Horizon (FHN) has drawn fresh attention after recent share moves, with the stock closing at US$22.13. For investors, that price invites a closer look at the bank’s fundamentals and current valuation. See our latest analysis for First Horizon. Over the past year, First Horizon’s 18.37% total shareholder return contrasts with a weaker recent patch, including a 30 day share price return of 9.64% decline. This suggests momentum has cooled even as longer term holders remain ahead. If First...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Strength And Updated Fair Value Estimate

Event driven snapshot of Madrigal Pharmaceuticals Madrigal Pharmaceuticals (MDGL) has drawn investor attention after recent share price moves, including a 1 day return of about 2% and a 16% gain over the past week, against mixed month and past 3 months performance. See our latest analysis for Madrigal Pharmaceuticals. The recent 15.8% 7 day share price return contrasts with a weaker year to date share price performance and a much stronger 1 year total shareholder return of 55.8%. This...
NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Is Concentrix (CNXC) Using AI And Capital Returns To Quietly Redefine Its Growth Playbook?

Concentrix recently reported its first-quarter 2026 results, issued second-quarter and full-year guidance, confirmed a US$0.36 quarterly dividend for May 5, 2026, completed a large share repurchase program, and added Chih-Kai Cheng and Bilge Ogut to its board at the March 26 AGM. The combination of revenue growth alongside weaker earnings, expanding AI-focused offerings, ongoing capital returns, and refreshed board oversight highlights a business in the middle of a significant transformation...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly Defends GLP‑1 Franchise As EBGLYSS Data Support Diversification

Eli Lilly (NYSE:LLY) secured a partial legal win in its case against Fella Health over alleged misleading marketing of compounded tirzepatide. The court allowed core claims around consumer confusion and false advertising to continue, while rejecting other elements of Lilly’s complaint. Separately, four year data from the ADlong Phase 3b extension study showed durable skin clearance and itch relief with EBGLYSS (lebrikizumab-lbkz) in atopic dermatitis. Both updates affect Lilly’s positioning...
TSX:CRR.UN
TSX:CRR.UNRetail REITs

A Look At Crombie Real Estate Investment Trust’s Valuation After Recent Unit Price Weakness

What Crombie Real Estate Investment Trust’s recent performance means for investors Crombie Real Estate Investment Trust (TSX:CRR.UN) has drawn attention after a recent 4.6% decline over the past month, even as its past 3 months and 1 year total returns remain in positive territory. This mix of shorter term weakness and longer term gains is prompting investors to reassess how Crombie’s CA$15.63 unit price, market value of about CA$2.9b, and income profile fit into their real estate...
NasdaqGM:ZNTL
NasdaqGM:ZNTLBiotechs

Zentalis Pharmaceuticals (ZNTL) Posts Zero Revenue Challenging Bullish Revenue Recovery Narratives

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...
TSX:WDO
TSX:WDOMetals and Mining

Is Wesdome’s New COO and Buyback Plan Quietly Reframing Its Capital Allocation Story (TSX:WDO)?

Wesdome Gold Mines Ltd. recently confirmed Tyler Mitchelson as its full-time Chief Operating Officer and implemented an automatic share purchase plan with National Bank Financial to execute its normal course issuer bid for up to 2% of the public float. Together, the leadership reinforcement and commitment to ongoing share repurchases highlight management’s focus on operational execution while actively managing Wesdome’s capital structure. We’ll now examine how the automatic share purchase...
BIT:GVS
BIT:GVSMedical Equipment

GVS (BIT:GVS) Q3 EPS Recovery With 5.4% Net Margin Tests Bullish Margin Narratives

GVS (BIT:GVS) has reported third quarter FY 2025 revenue of €99.958 million and basic EPS of €0.043, while trailing 12 month EPS sits at €0.123 on revenue of €422.421 million, alongside earnings growth of 31.7% over the past year. Over recent periods, the company has seen quarterly revenue range from €106.868 million in Q4 2024 to €108.39 million in Q2 2025. Basic EPS moved from €0.077 in Q4 2024 to a loss of €0.004 in Q2 2025 before recovering in Q3 2025, which may lead investors to focus on...
NYSE:NWN
NYSE:NWNGas Utilities

Is It Too Late To Consider Northwest Natural Holding (NWN) After A 30% One-Year Rally?

Wondering if Northwest Natural Holding at US$52.83 is priced attractively or already reflects most of its potential? This article walks through the numbers so you can judge the valuation for yourself. The stock has returned 2.7% over the last 7 days, 5.7% over 30 days, 13.0% year to date and 29.6% over 1 year, with 3-year and 5-year returns of 27.9% and 23.9% respectively. These returns naturally raise questions about what is now baked into the price. Recent coverage has focused on how gas...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Is Sprouts (SFM) Using Premium Pet Nutrition To Quietly Reinforce Its Health-Focused Brand Edge?

Get Joy, a functional gut-healthy dog nutrition company, has already rolled out its Freeze Dried Raw Chicken and Beef Meals into more than 360 Sprouts Farmers Market stores nationwide, following its nationwide launch that began on April 6. This expansion broadens Sprouts’ better-for-you pet assortment, aligning its pet aisles with wellness trends that increasingly mirror how customers shop for their own nutrition. Next, we’ll explore how adding Get Joy’s gut-focused dog meals could influence...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

Hut 8 Gains Spotlight As Infrastructure Backbone For Bitcoin Accumulation Plans

American Bitcoin Corp. has highlighted Hut 8 (NasdaqGS:HUT) as a key infrastructure partner. The company described Hut 8 as a "Bitcoin accumulation machine," underscoring its role in large scale mining operations. This recognition focuses on Hut 8's infrastructure that supports efficient Bitcoin mining and long term accumulation plans. For you as an investor, this puts fresh attention on what Hut 8 actually does in the Bitcoin mining value chain. Rather than only operating its own mining...
OTCPK:PPLL
OTCPK:PPLLBanks

Peoples (OTCPK:PPLL) Earnings Growth Of 40.1% Tests Cautious Narratives

Peoples (OTCPK:PPLL) has just wrapped up FY 2025 with fourth quarter revenue of US$6.5 million and basic EPS of US$1.37, alongside trailing 12 month EPS of US$5.59 supported by net income of US$10.11 million on revenue of US$25.7 million. Over recent quarters, revenue has moved from US$5.4 million in Q4 2024 to US$7.1 million in Q3 2025 before landing at US$6.5 million in Q4 2025, with quarterly EPS ranging from US$1.06 in Q4 2024 to a peak of US$1.74 in Q3 2025. With trailing net profit...